Biotech

All Articles

FDA junks adcomm for Applied's unusual ailment drug

.After dismissing the selection meeting for Applied Therapeutics' metabolic disorder medication govo...

Novo inks $600M NanoVation bargain to analyze hereditary drugs ex-liver

.Novo Nordisk is continuing its push right into hereditary medicines, accepting to compensate NanoVa...

Innovent hyperlinks cytokine to colon cancer cells actions

.Innovent Biologics has actually created the instance that its gate inhibitor-cytokine fusion health...

Merck, Daiichi ADC hits target in phase 3 bronchi cancer cells research study

.A period 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina strengthens AI focus along with collab to choose cancer cells intendeds

.5 months after Rakovina Therapies pivoted towards expert system, the cancer-focused biotech has act...

Ascendis' dwarfism medication hits in phase 3, intimidates BioMarin

.Ascendis Pharma has actually emerged as a potential threat to BioMarin's Voxzogo, reporting phase 3...

Despite ph. 3 overlook, Alkeus observes path ahead of time for eye health condition property

.Though Alkeus Pharmaceuticals' oral eye disease possession failed to substantially lessen geographi...

Kairos goes public along with $6M IPO to finance trials of cancer drug

.With a trio of biotechs striking the Nasdaq on Friday, it was quick and easy to miss a smaller-scal...

Vaccine and also Keytruda combo successful in squamous cell carcinoma

.Invulnerable gate preventions are actually the superheroes of cancer cells therapy. Drugs like Bris...

Cue Biopharma mark time J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of substantial management hirings, firings ...